The Amyloidosis Foundation grant program has supported outstanding research in all forms of systemic amyloidosis. Through our research program we encourage, promote and invest in the medical study and exploration of the amyloidosis diseases.
Deadline: August 31, 2016Read More
Quality of Life Research Grants have been created to support quality of life cancer research that has the potential to make a significant impact on the burden of disease in patients, survivors and caregivers. These grants are intended to explore psychosocial, survivorship, symptom control, supportive care and end-of-life issues, research gaps, needs and opportunities, or models for survivorship care. The grants are meant to accelerate and focus the knowledge gained from scientific findings, in the short or long term, into outcomes that will result in the reduced burden or enhanced quality of life for cancer patients in Canada and elsewhere.
Deadline for letter of intent: June 29, 2016Read More
CCF offers funding for basic science, clinical, population/ epidemiologic and translational research on cardiomyopathies affecting children aged 18 years and younger. This includes support for studies focused on the causes, diagnosis or treatment of dilated, hypertrophic, restrictive, arrhythmogenic right ventricular and left ventricular non-compaction cardiomyopathy.
Deadline for Letters of Intent: June 15, 2016Read More
The Autism Research Program focuses on ways to improve diagnosis, treatment, and studying psychosocial factors for affecting key life time transitions to independence and a better life for those with autism and their families. The FY 2016 program includes two funding mechanisms: Clinical Trial Awards; and Idea Development Awards.
Deadline for Pre-Application: June 22, 2016Read More
The LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer.
Deadline for pre-applications: June 9, 2016Read More
The mission of the MSRP is to identify and fund promising research projects that are relevant to the prevention, etiology, pathogenesis, assessment, and treatment of MS and to ultimately lessen its personal and societal impact.
Deadline for pre-applications: May 26, 2016Read More
"The Peer Reviewed Cancer Research Program (PRCRP) has been charged by U.S. Congress to fund innovative basic, applied, and translational cancer research to support Service members, their families, and the American public "
Deadline for pre-applications: June 8, 2016Read More
The goal of the program is to offer support for investigator-initiated research directed to better understand the biology of Huntington's disease (HD) as it occurs in humans. The research projects and observations resulting from them should have the potential to directly impact the lives of patients or help guide future drug development for HD.
Deadline for letter of intent: May 23, 2016Read More
The objective is to accelerate discoveries in fundamental Rett syndrome research toward clinical testing, with the goal of improving the lives and treatments of those diagnosed with Rett syndrome. Our emphasis on translational and clinical research will ensure that new ideas are constantly flowing into the drug pipeline and neuro-habilitation platforms aimed at accelerating treatments for Rett syndrome.
Deadline for letter of intent: May 31, 2016Read More
The LAM Foundation offers funding for research by new and established investigators into Lymphangioleiomyomatosis (LAM).
Deadline for letter of intent: July 15, 2016Read More
"The Lung Cancer Research Foundation is proud to fund research that they believe will make major contributions toward better treatments, screening, and prevention of lung cancer. "
Deadline: July 1, 2016Read More
Eligible projects may relate to benchwork, translational or clinical research that is not presently funded and may be conducted through any not-for-profit academic, medical or research institution. We encourage all levels and degrees of scientists to apply.
Deadline: August 5, 2016Read More
The Grant Program supports basic and clinical research on restless legs syndrome (RLS). Funding priorities include basic and clinical research to promote a better understanding of the disease, advance new treatments and find a cure for RLS.
Deadline: ContinuousRead More
"2016 GRO Program is seeking proposals in twenty four (24) research themes. Other themes are also welcome. - AR/VR - IoT - Next Generation Computing - Machine Learning & Recognition - Natural Language Processing - Neural Processor - Artificial Intelligence - Autonomous Driving - Software Engineering - Robotics for Human Augmentation - Security & Privacy - Data Analytics - Sensor Technology - 5G Mobile Applications - System Arch. for Storage & Memory - 2D Materials/Devices - Next Gen. Sensors & Detectors - Energy Harvesting - Inorganic Photonic Materials - Functional Material - Organic Materials - Microbial Conversion Materials - Nano Structuring - Material Informatics.""
Deadline: June 14, 2016Read More
The Saving tiny Hearts Society’s mission is to raise seed money for grossly under-funded, lifesaving grass roots research of congenital heart defects (CHD's).
Deadline: July 1, 2016Read More
Researchers can submit applications to access stored blood, urine and DNA biospecimens from the Canadian Health Measures Survey (CHMS).
Deadlines: June 30, 2016Read More
TS Alliance endeavors to stimulate, support and coordinate research that will lead to a cure for tuberous sclerosis complex (TSC), while improving the lives of those affected.
Deadline for letter of intent: June 20, 2016Read More
"The Weston Brain Institute is delighted to launch our Canada: Rapid Response 2016 program to provide seed funding for novel, high-risk, high-reward translational research. NEW for 2016: The program will have 3 application rounds, focused on two different disease groups. Applicants should apply to the group best suited to their project. Each PI may submit one application per round as the Principal Applicant or the Administrative Supervisor. "
"Deadline for letter of intent for Round 2: PD-related diseases (PD, PSP, DLB, MSA and prodromes) : June 27, 2016 Deadline for letter of intent Round 3: AD-related diseases (AD, FTD, MCI and prodromes): July 28, 2016"Read More
Western researchers can consult Pivot, a comprehensive database of grant information.